Barnett & Company’s Teladoc Health TDOC Stock Holding History

Barnett & Company’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19	Closed	-$2K	–	243
2021 Q4	$2K	Buy	+19	New	+$2.27K	﹤0.01%	269

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barnett & Company's TDOC Position: Q1 2022 in Review

Barnett & Company sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 19 shares — an estimated $2K sold.

Barnett & Company first reported a position in TDOC in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

Barnett & Company reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
Barnett & Company sold 19 Teladoc Health shares in Q1 2022, an estimated $2K.
Barnett & Company first reported a position in Teladoc Health in Q4 2021 and held it in 1 quarter.
Barnett & Company's Teladoc Health position peaked at $2K in Q4 2021.
679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Barnett & Company's 13F filing for Q1 2022, filed 28 Apr 2022.